CYP7A1, a member of the cytochrome P450 superfamily, is a critical enzyme involved in the rate-limiting step of bile acid biosynthesis in the liver. Its discovery dates back to the late 1980s when researchers elucidated its pivotal role in cholesterol catabolism and bile acid synthesis. By catalyzing the conversion of cholesterol into 7-alpha-hydroxycholesterol, CYP7A1 initiates the classic bile acid biosynthesis pathway. This process regulates cholesterol homeostasis and facilitates lipid absorption and metabolism. Given its significance, efforts have been directed towards understanding its regulation and function. Consequently, the establishment of stable cell lines expressing human CYP7A1, such as HepG2, has emerged as a valuable tool for investigating its physiological roles and potential therapeutic targets. These cell lines, developed through rigorous molecular biology techniques, provide a platform for studying the intricate mechanisms governing bile acid metabolism and its implications in health and disease.
Bile acids, derived from liver cholesterol, regulate lipid absorption and cholesterol balance. Researchers elucidated the crucial role of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in regulating cholesterol homeostasis and dietary lipid absorption. They discovered that estrogen-related receptor γ (ERRγ) acts as a novel transcriptional regulator of CYP7A1 expression. Activation of cannabinoid receptor type 1 (CB1 receptor) signaling induced ERRγ-mediated transcription of CYP7A1, while ERRγ overexpression increased CYP7A1 expression. Conversely, knockdown of ERRγ attenuated CYP7A1 expression. Small heterodimer partner (SHP) inhibited ERRγ's transcriptional activity, regulating CYP7A1 expression. Furthermore, the inverse agonist of ERRγ, GSK5182, reduced CYP7A1 expression and bile acid synthesis. These findings offer insights into the molecular mechanisms linking ERRγ and bile acid metabolism.
Figure 1. Researchers demonstrate that GSK5182 inhibits CYP7A1 gene expression, reducing bile acid synthesis. This effect is observed in AML12 cells through luciferase and β-galactosidase assays, qPCR, Western blot analysis, and bile acid level measurements. (Zhang Y, et al., 2022)
Using Creative Biogene's Human CYP7A1 Stable Cell Line - HepG2 can make experiments more convenient and reliable. Compared to traditional cell transfection experiments, this stable cell line ensures continuous expression of the CYP7A1 gene, avoiding the hassle of cell transfection for each experiment. This not only saves time and experimental resources but also helps reduce variability in experiments, improving the repeatability and reliability of the data. Therefore, using this stable cell line can more effectively study the expression of the CYP7A1 gene and bile acid synthesis, providing stronger support for the interpretation of experimental results.
1. Drug metabolism studies: Utilize Human CYP7A1 Stable Cell Line - HepG2 to investigate the metabolic pathways of pharmaceutical compounds.
2. Toxicity assessment: Assess the potential hepatotoxicity of drugs by examining their effects on CYP7A1 expression in HepG2 cells.
3. Cholesterol regulation research: Study the impact of novel compounds on cholesterol metabolism by monitoring CYP7A1 activity in engineered HepG2 cells.
4. Disease modeling: Create disease models related to lipid metabolism disorders using HepG2 cells expressing human CYP7A1.
5. Drug screening assays: Develop screening assays to identify compounds that modulate CYP7A1 expression or activity, aiding in drug discovery efforts.
6. Mechanistic studies: Investigate the molecular mechanisms underlying CYP7A1 regulation and its implications in various metabolic diseases using HepG2 cell models.
7. Gene expression analysis: Analyze gene expression profiles in response to different treatments or conditions in CYP7A1-expressing HepG2 cells to understand regulatory pathways.
Customer Q&As
What factors influenced the choice of HepG2 cells for establishing the stable CYP7A1 cell line?
A: HepG2 cells were likely selected due to their hepatic origin, retaining many characteristics of primary hepatocytes, making them suitable for studying CYP7A1 expression and bile acid metabolism.
How was the stability of CYP7A1 expression verified and maintained in this HepG2 stable cell line?
A: Stability was likely confirmed through methods such as immunoblotting, qPCR, or enzyme activity assays, with continuous selection pressure applied to ensure stable maintenance of CYP7A1 expression.
Can you elaborate on the characterization of CYP7A1 expression in the HepG2 stable cell line, including its metabolic activity and regulatory mechanisms?
A: Characterization may involve assessment of CYP7A1 enzyme activity, regulation by nuclear receptors, bile acid synthesis, and functional implications in cholesterol homeostasis and liver physiology.
What quality control measures were employed during the generation of this stable cell line?
A: Quality control likely included screening for mycoplasma contamination, confirmation of stable transgene integration, and assessment of phenotypic stability and consistency.
How does the expression pattern and functional properties of CYP7A1 in this stable cell line correspond to its physiological roles and relevance in liver metabolism and disease?
A: Comparative analysis with primary hepatocytes or in vivo models helps validate the relevance of CYP7A1 expression in bile acid synthesis, cholesterol metabolism, and liver diseases such as cholestasis and dyslipidemia.
Ask a Question
Customer Reviews
Stable CYP7A1 expression
This Human CYP7A1 Stable Cell Line is a game-changer! Its stable expression in HepG2 cells has simplified my research on bile acid synthesis pathways.
Research propulsion
Using this cell line feels like having a magic wand! The stable CYP7A1 expression has made studying cholesterol metabolism regulation a breeze.
United Kingdom
04/07/2021
Reliable CYP7A1 expression
Can't believe how much smoother my experiments have become with this cell line! Its reliable expression in HepG2 cells has brought clarity to my research on liver metabolism.
Confidence
So impressed with this Human CYP7A1 Stable Cell Line! Its consistent expression has given me confidence in my findings and propelled my research forward.
Simplified work with CYP7A1
Huge shoutout to this cell line for simplifying my work! With stable CYP7A1 expression, I can delve deeper into bile acid synthesis without any worries.
Write a Review